ABSL Pharma & Healthcare Reg Gr logo

ABSL Pharma & Healthcare Reg Gr

Sector - HealthcareAditya Birla Sun Life Mutual Fund

NAV

₹34.23

-0.17% today

AUM

₹1,102.73 Cr

Fund size

Expense

1.90%

Regular plan

Min SIP

₹100

per month

Min Lumpsum

₹1,000

one-time

Exit Load

1.0

on redemption

Fund snapshot

Category rank#6 of 10
Risk-o-meterVery High Risk
BenchmarkBSE Healthcare TR INR (100%)
Number of holdings39
Inception11 Jul 2019
Exit load1.0

Risk metrics

Alpha0.3
Beta0.9
Sharpe ratio0.95
Standard deviation15.26%
Sortino ratio1.69

Capital gains tax

Equity

STCG · short-term

20%

Short-term gains taxed at 20%

Applies when equity fund units are sold within 12 months.

LTCG · long-term

12.5%

Long-term gains taxed at 12.5%

Applies when equity fund units are sold after 12 months.

Equity-oriented mutual fund taxation applies based on holding period.

Fund managers

DS

Since Jul 2019

AUM managed

₹17,452.98Cr

Tenure

Since Jul 2019

Funds

3

About ABSL Pharma & Healthcare Reg Gr

ABSL Pharma & Healthcare Reg Gr is an open-ended Sector - Healthcare mutual fund scheme offered by Aditya Birla Sun Life Mutual Fund under the regular plan with the growth option. Its latest net asset value (NAV) is ₹34.23 per unit and the scheme manages ₹1,102.73 Cr in assets under management. The fund charges an expense ratio of 1.90% and is benchmarked against BSE Healthcare TR INR (100%). Over the trailing 5 years, ABSL Pharma & Healthcare Reg Gr has delivered +11.47% returns. SEBI's riskometer places this scheme in the Very High Risk category, so read the scheme information document before investing.

Investment objective

The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.

Regular Plan · Growth option · NAV as of 15 Oct 2026

ABSL Pharma & Healthcare Reg Gr returns

Trailing returns. Periods above one year are annualised (CAGR); one year and below are absolute.
PeriodFundCategory average
1 month-4.73%-5.83%
3 months-4.63%-3.41%
6 months+10.78%+13.35%
1 year+10.17%+10.74%
3 years+17.39%+19.18%
5 years+11.47%+12.83%

Rolling returns

Average return across every rolling window of this length over the fund's history.
PeriodFundCategory average
1 month---3.44%
3 months+11.99%+1.95%
6 months+18.51%+19.58%
1 year+19.94%+17.08%
3 years+79.35%+73.64%
5 years+85.87%+91.32%

Past performance is not indicative of future returns. Mutual fund investments are subject to market risks; read all scheme related documents carefully.

ABSL Pharma & Healthcare Reg Gr — frequently asked questions

What is the NAV of ABSL Pharma & Healthcare Reg Gr?

The latest net asset value (NAV) of ABSL Pharma & Healthcare Reg Gr is ₹34.23 per unit, -0.17% over the previous trading day. NAV is declared by the AMC at the end of every business day.

What returns has ABSL Pharma & Healthcare Reg Gr delivered?

ABSL Pharma & Healthcare Reg Gr has returned +11.47% over the trailing 5 years (1 year: +10.17%, 3 years: +17.39%). Returns beyond one year are annualised. Past performance does not guarantee future returns.

What is the expense ratio of ABSL Pharma & Healthcare Reg Gr?

ABSL Pharma & Healthcare Reg Gr charges an expense ratio of 1.90% per annum. The expense ratio is deducted from the scheme's assets, so the NAV you see is already net of it.

How risky is ABSL Pharma & Healthcare Reg Gr?

SEBI's riskometer classifies ABSL Pharma & Healthcare Reg Gr as Very High Risk, which is typical for a Sector - Healthcare scheme. Match the scheme's risk level to your own risk tolerance and investment horizon before investing.

What is the minimum investment in ABSL Pharma & Healthcare Reg Gr?

You can start a SIP in ABSL Pharma & Healthcare Reg Gr from ₹100 per month, and the minimum lumpsum investment is ₹1,000.

Who manages ABSL Pharma & Healthcare Reg Gr?

ABSL Pharma & Healthcare Reg Gr is managed by Aditya Birla Sun Life Mutual Fund, holds ₹1,102.73 Cr in assets under management and invests across 39 holdings. This page covers the regular plan with the growth option.

Scheme identifiers

Scheme category
Equity
Scheme sub-category
Sector - Healthcare
Plan
Regular plan
Option
Growth
ISIN
INF209KB1N91
Scheme code
FS0000FE4Y